Division of Nephrology-Hypertension, University of California-San Diego, San Diego, California.
Department of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
JACC Cardiovasc Interv. 2017 Oct 23;10(20):2101-2110. doi: 10.1016/j.jcin.2017.05.050.
This study aimed to describe the temporal trends and outcomes of endovascular and surgical revascularization in a large, nationally representative sample of patients with end-stage renal disease on hemodialysis hospitalized for peripheral artery disease (PAD).
PAD is prevalent among patients with end-stage renal disease on hemodialysis and is associated with significant morbidity and mortality. There is a paucity of information on trends in endovascular and surgical revascularization and post-procedure outcomes in this population.
We used the Nationwide Inpatient Sample (2002 to 2012) to identify hemodialysis patients undergoing endovascular or surgical procedures for PAD using diagnostic and procedural codes. We compared trends in amputation, post-procedure complications, mortality, length of stay, and costs between the 2 groups using trend tests and logistic regression.
There were 77,049 endovascular and 29,556 surgical procedures for PAD in hemodialysis patients. Trend analysis showed that endovascular procedures increased by nearly 3-fold, whereas there was a reciprocal decrease in surgical revascularization. Post-procedure complication rates were relatively stable in persons undergoing endovascular procedures but nearly doubled in those undergoing surgery. Surgery was associated with 1.8 times adjusted odds (95% confidence interval: 1.60 to 2.02) for complications and 1.6 times the adjusted odds for amputations (95% confidence interval: 1.40 to 1.75) but had similar mortality (adjusted odds ratio: 1.05; 95% confidence interval: 0.85 to 1.29) compared with endovascular procedures. Length of stay for endovascular procedures remained stable, whereas a decrease was seen for surgical procedures. Overall costs increased marginally for both procedures.
Rates of endovascular procedures have increased, whereas those of surgeries have decreased. Surgical revascularization is associated with higher odds of overall complications. Further prospective studies and clinical trials are required to analyze the relationship between the severity of PAD and the revascularization strategy chosen.
本研究旨在描述在一个大型的、具有全国代表性的血液透析终末期肾病患者人群中,接受血管内和手术血运重建治疗的外周动脉疾病(PAD)住院患者的时间趋势和结局。
PAD 在血液透析终末期肾病患者中很常见,与显著的发病率和死亡率相关。在该人群中,关于血管内和手术血运重建以及术后结果的趋势信息很少。
我们使用全国住院患者样本(2002 年至 2012 年),通过诊断和程序代码确定接受血管内或手术治疗 PAD 的血液透析患者。我们使用趋势检验和逻辑回归比较了两组之间的截肢、术后并发症、死亡率、住院时间和成本的趋势。
在血液透析患者中,有 77049 例血管内和 29556 例手术治疗 PAD。趋势分析显示,血管内手术几乎增加了 3 倍,而手术血运重建则相应减少。血管内手术患者的术后并发症发生率相对稳定,但手术患者的并发症发生率几乎增加了一倍。与血管内手术相比,手术与调整后的并发症发生率增加 1.8 倍(95%置信区间:1.60 至 2.02)和调整后的截肢发生率增加 1.6 倍(95%置信区间:1.40 至 1.75),但与血管内手术相比,死亡率相似(调整后的比值比:1.05;95%置信区间:0.85 至 1.29)。血管内手术的住院时间保持稳定,而手术的住院时间则有所下降。两种手术的总体费用都略有增加。
血管内手术的比例增加,而手术的比例下降。手术血运重建与更高的总体并发症发生率相关。需要进一步的前瞻性研究和临床试验来分析 PAD 的严重程度与所选择的血运重建策略之间的关系。